Description
GLP-1S (Research Compound)
Tagline: Advanced GLP-1 Analogue
Product Description
GLP-1S is a synthetic analogue of glucagon-like peptide-1 (GLP-1), designed for laboratory and scientific research only. Researchers study this compound for its unique role in metabolism regulation, insulin signaling, and cardiovascular pathways. Due to its high stability and structural similarity to endogenous GLP-1, GLP-1S offers consistent results in controlled experimental environments.
This compound is not intended for human use, treatment, or diagnostic purposes. All applications must remain strictly within research settings.
Why Researchers Choose GLP-1S
-
High purity for reproducible results
-
Strong stability under proper storage conditions
-
Reliable solubility for precise dosing in experiments
-
Widely studied in metabolic and cardiovascular research models
-
Easy to handle and reconstitute for laboratory protocols
Research Data & Handling Tips
-
Reconstitution: Reconstitute in sterile water or a buffer solution under aseptic conditions.
-
Solubility: Soluble in aqueous buffers and DMSO.
-
Storage: Store lyophilized powder at –20°C. After reconstitution, keep aliquots at –80°C to avoid degradation.
-
Stability: Stable for up to 24 months (lyophilized). Use within 4–8 weeks after reconstitution.
Important Note
For laboratory and scientific research only. Not for human consumption.Semaglutide
Research
Research
Metabolism & Insulin Sensitivity
GLP-1S is commonly studied for its effects on glucose metabolism and insulin regulation. Research indicates that GLP-1 analogues may influence beta-cell activity and insulin secretion in animal and cell models [1].
Cardiovascular Function
Studies explore the compound’s role in cardiovascular health, particularly in how GLP-1 receptor activity may impact blood pressure regulation and vascular inflammation [2].
Appetite & Energy Balance
Experimental data suggest that GLP-1S can influence hypothalamic signaling pathways, affecting food intake and energy expenditure in controlled studies [3].
Neuroprotection & Cognitive Health
Preclinical findings indicate potential roles for GLP-1 analogues in neuroprotection and memory pathways, though mechanisms are still under investigation [4].
References
-
Holst JJ (2007). The physiology of glucagon-like peptide 1. Physiol Rev. https://journals.physiology.org/doi/pdf/10.1152/physrev.00034.2006
-
Nauck MA, Quast DR, Wefers J, Meier JJ (2021). GLP-1 receptor agonists in cardiovascular outcomes: state-of-the-art. Lancet Diabetes Endocrinol.
https://europepmc.org/article/MED/34181914
-
van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH (2014). Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite, and energy metabolism in obese, non-diabetic adults. Diabetes Obes Metab.
https://europepmc.org/articles/PMC4052428
-
Hölscher C (2019). Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. Prog Brain Res.
https://europepmc.org/article/MED/23999914
-
Drucker DJ (2018). “Mechanisms of action and therapeutic application of GLP-1 analogues.” Cell Metabolism.
https://www.cell.com/cell-metabolism/fulltext/S1550-4131%2818%2930179-7